Press Release

Autism Spectrum Disorder Therapeutics Market report covers top players as Allergan, Q BioMed Inc, Hopebridge, LLC., Center for Autism and Related Disorders., Behavior Innovations, Applied Behavior Consultants, Fusion Autism Center, Otsuka Holdings Co. Ltd., AstraZeneca, Pfizer Inc., Eli Lilly and Company., Johnson & Johnson Services, Inc.

Autism Spectrum Disorder Therapeutics Market Size, Share, Trend, Global Analysis, Key Players Demand and Future Outlook 2026

According to a report published by Fortune Business Insights, titled, “Autism Spectrum Disorder Therapeutics Market: Global Market Analysis, Insights and Forecast, 2018-2026,” the global market is likely to reach US$ 4,612.1 Mn by 2026 owing to the rising incidence of autism spectrum disorder worldwide.

The report provides valuable insights into the global market trends and factors that are directly affecting the growth of the market. As per the report, the global autism spectrum disorder therapeutics market was worth US$ 3,293.0 Mn in 2018. Considering the increasing awareness programs regarding this particular disorder and less availability of treatment options, the global market is expected to rise at a moderate CAGR of 4.3% during the forecast period (2019-2026).

Get Sample PDF Brochure:

Some of the major companies that are present in the Global Autism Spectrum Disorder Therapeutics Market are;

  • Allergan
  • Q BioMed Inc
  • Hopebridge, LLC.
  • Center for Autism and Related Disorders.
  • Behavior Innovations
  • Applied Behavior Consultants
  • Fusion Autism Center
  • Otsuka Holdings Co. Ltd.
  • AstraZeneca
  • Pfizer Inc.
  • Eli Lilly and Company.
  • Johnson & Johnson Services, Inc.

The report further states that the number of children diagnosed with autism is increasing day by day across the globe. This, combined with favorable reimbursement scenario, will increase the demand for applied behavioral analysis therapies. Such therapies aid in improving learning and physical disabilities in autistic children. Furthermore, FDA approvals of numerous medicines that are used to manage autism spectrum disorder are expected to propel the global autism spectrum disorder therapeutics market during the forecast period.

Autistic Disorder Segment to Witness Growth Owing to the Rising Prevalence of the Disease

The global autism spectrum disorder therapeutics market is grouped into drug therapy and communication and behavioral therapy in terms of treatment type. Amongst these, the communication and behavioral therapy segment was in the leading position in the global market. Fortune Business Insights predicts that it will retain its position throughout the forecast period. In terms of type, the autism spectrum disorder therapeutics market is classified into Asperger syndrome, autistic disorder, pervasive development disorder, and others. Out of these, the autistic disorder segment procured the highest autism spectrum disorder therapeutics market share in the year 2018. It is anticipated to witness significant growth in the coming years. This growth is attributed to the increasing prevalence of this disorder.


By Type

  • Autistic Disorder
  • Asperger Syndrome
  • Pervasive Developmental Disorder
  • Others

By Treatment Type

  • Communication & Behavioral Therapies
  • Drug Therapies

By Geography

Browse Complete Report Details:

Fusion Autism Center Opens its New Therapy Center to Provide Pediatric Services

Several renowned market players have begun investing huge sums in the research and development of advanced and effective drugs for the treatment of autism spectrum disorder. This will contribute to the global autism spectrum disorder therapeutics market growth in the coming years. Below are three latest initiatives that have been recently taken by the prominent market players to drive global market sales:

  • Fusion Autism Center (FAC), a mental health service provider, based in the U.S.A., announced in February 2019 that it has successfully expanded its center-based services of Applied Behavioral Analysis therapy for kids on the autism spectrum. The new center is built in Augusta so that it would provide much-needed services to the communities with special needs residing in the area. Apart from that, FAC has its centers in Roswell, Woodstock, Cumming, Peachtree, and Duluth.
  • Hoffmann-La Roche Ltd., a multinational healthcare company, headquartered in Switzerland, announced that the FDA has approved Breakthrough Therapy Designation for its oral medication balovaptan in January 2018. The investigational oral medicine has the potential to improve communication and interaction abilities of those affected with autism spectrum disorder.
  • Q BioMed Inc., a prominent developer of biomedical assets, based in New York, announced in June 2018 that it has applied for Orphan Drug status with European and the U.S. regulators for QBM-001, the company’s pediatric autism drug.

Fortune Business Insights has profiled some of the key market players operating in the global autism spectrum disorder therapeutics market. They are Applied Behavior Consultants, Allergan, Pfizer Inc., Q BioMed Inc, Fusion Autism Center, Center for Autism and Related Disorders, AstraZeneca, Hopebridge, LLC., Johnson & Johnson Services, Inc., Behavior Innovations, Eli Lilly and Company, Otsuka Holdings Co. Ltd., and other prominent market players.

Get Discount:

More Trending Topics from Fortune Business Insights:

Cosmetic Dentistry Market Top 10 Players Size, Share, Recent Development Trends, Analysis and Forecast 2019-2026

Hospital Information Systems Market Research Report 2019 Global Industry Analysis, Business Development, Size, Share, Trends, Future Growth, Forecast to 2026


Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *